Gregg Van de Putte - Concepedia

Author

Gregg Van de Putte

Also Known As

G Van de Putte, G van de Putte, G. Van De Putte, G. Van de Putte, G. van de Putte, Gregg Van de Putte, Gregg van de Putte, Van De Putte, G.

Publications

758

Citations

H-Index

Concepts

All Affiliations

Norwegian Cancer Society University of Oslo Ziekenhuis Oost-Limburg Sheba Medical Center Hebrew University of Jerusalem

About

Gregg Van de Putte is an author at Norwegian Cancer Society specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	472
2	Public Health	5	5	382
3	Cell Biology	3	3	143
4	Obstetrics	3	3	227
5	Biostatistics	1	1	144

Gregg Van de Putte

Publications

728

Citations

H-Index

Page 1

	Year	Citations
Intrauterine insemination after ovarian stimulation with clomiphene citrate: predictive potential of inseminating motile count and sperm morphology Willem Ombelet, H. Vandeput, Gregg Van de Putte, Human Reproduction Motile CountFertilityIui CyclesReproductive HealthGynecology	1997	144
Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis Gregg Van de Putte, Ruth Holm, A. Kathrine Lie, Gynecologic Oncology Cervical CancerPrecancerous LesionsMedicineSquamous Cervical CancerPathology	2003	82
Risk grouping in stage IB squamous cell cervical carcinoma Gregg Van de Putte, A. Kathrine Lie, Werner Vach, Gynecologic Oncology Cervical Cancer ManagementCancer RiskCervical CancerMedicinePathology	2005	71
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. B.R. Davidson, Philip Lazarovici, A. Ezersky, PubMed	2001	57
Adnexal Masses in Pregnancy Ralph H.M. Hermans, D.-C. Fischer, H.W.H.M. van der Putten, Oncology Research and Treatment Reproductive HealthFetal MedicineGynecologyAdnexal MassesSurgery	2003	52
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions Ben Davidson, Reuven Reich, Juri Kopolovic, Clinical & Experimental Metastasis	2002	49
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma – diagnostic and prognostic implications Heidi S. Berner, Ben Davidson, Aasmund Berner, Clinical & Experimental Metastasis	2000	47
A Novel Approach to Predict the Likelihood of Specific Ovarian Tumor Pathology Based on Serum CA-125: A Multicenter Observational Study Ben Van Calster, L. Valentin, Caroline Van Holsbeke, Cancer Epidemiology Biomarkers & Prevention	2011	39
Cyclins and proliferation markers in early squamous cervical carcinoma Gregg Van de Putte Gynecologic Oncology Precancerous LesionsCervical CancerProliferation MarkersPathologyCytopathology	2004	33
Expression of Cell Cycle Proteins in Ovarian Carcinoma Cells in Serous Effusions—Biological and Prognostic Implications Ben Davidson, Bjørn Risberg, Aasmund Berner, Gynecologic Oncology Serous Effusions—biologicalMedicineGynecologyCancer Cell BiologyCell Cycle Proteins	2001	31

Page 1